Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-03-17 Purchase | 2020-03-19 12:48 pm | BELLICUM PHARMACEUTICALS INC | BLCM | Fair Richard A. President and CEO | 5,000 | $3.9997 | $19,999 | 11,813 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-08-15 Option Award | 2022-08-16 5:04 pm | N/A 2032-08-15 | BELLICUM PHARMACEUTICALS INC | BLCM | Fair Richard A. President and CEO | 400,000 | $1.44 | 400,000 (Direct) | View |
2021-08-16 Option Award(A) | 2021-08-18 12:21 pm | 2022-08-16 2031-08-16 | BELLICUM PHARMACEUTICALS INC | BLCM | Fair Richard A. President and CEO | 265,000 | $0 | 265,000 (Direct) | View |
2021-08-16 Option Award | 2021-08-16 4:21 pm | N/A 2031-08-16 | BELLICUM PHARMACEUTICALS INC | BLCM | Fair Richard A. President and CEO | 265,000 | $0 | 265,000 (Direct) | View |
2021-06-10 Option Award | 2021-06-11 8:48 pm | N/A 2031-06-10 | Clovis Oncology Inc. | CLVS | Fair Richard A. Director | 42,223 | $0 | 42,223 (Direct) | View |
2020-12-15 Option Award | 2020-12-16 1:54 pm | N/A 2030-12-14 | BELLICUM PHARMACEUTICALS INC | BLCM | Fair Richard A. President and CEO | 286,000 | $0 | 286,000 (Direct) | View |
2020-06-04 Option Award | 2020-06-08 8:30 pm | N/A 2030-06-04 | Clovis Oncology Inc. | CLVS | Fair Richard A. Director | 40,138 | $0 | 40,138 (Direct) | View |
2020-02-03 Option Award | 2020-02-04 2:24 pm | N/A 2030-02-02 | BELLICUM PHARMACEUTICALS INC | BLCM | Fair Richard A. President and CEO | 1,257,000 | $0 | 1,257,000 (Direct) | View |